Skip to main content
. 2020 Dec 18;35(50):e434. doi: 10.3346/jkms.2020.35.e434

Table 2. Clinical outcomes according to groups.

Clinical outcomes Total (n = 7,341) Non-CKD (n = 7,088) ND-CKD (n = 239) DD-CKD (n = 14) P value
Acute kidney injury 27 (0.37) 24 (0.34) 3 (1.26) - 0.021
Inotropics use 187 (2.5) 170 (2.4) 12 (5.0) 5 (35.7) < 0.001
Conventional oxygen therapy 909 (12.4) 827 (1.6) 74 (31.0) 8 (57.1) < 0.001
High flow nasal cannula 182 (2.5) 165 (2.3) 13 (5.4) 4 (28.6) < 0.001
Mechanical ventilation 127 (1.7) 114 (1.6) 9 (3.8) 4 (28.6) < 0.001
ECMO 21 (0.3) 19 (0.3) 1 (0.4) 1 (7.1) < 0.001
Cardiac arrest 43 (0.6) 37 (0.5) 5 (2.1) 1 (7.1) < 0.001
Myocardial infarction 257 (3.5) 239 (3.4) 17 (7.1) 1 (7.1) 0.006
Acute heart failure 382 (5.2) 361 (5.1) 19 (8.0) 2 (14.3) 0.046

The data are expressed as the number (%).

ECMO = extracorporeal membrane oxygenation, Non-CKD = non-chronic kidney disease, ND-CKD = non-dialysis-chronic kidney disease, DD-CKD = dialysis dependent chronic kidney disease.